BioScrip Inc  

(Public, NASDAQ:BIOS)   Watch this stock  
Find more results for David Trujillo
+0.03 (1.12%)
Real-time:   1:56PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.66 - 2.72
52 week 1.19 - 3.09
Open 2.66
Vol / Avg. 501,645.00/1.35M
Mkt cap 302.78M
P/E     -
Div/yield     -
EPS -4.46
Shares 108.78M
Beta 0.69
Inst. own 74%
Aug 8, 2016
Q2 2016 BioScrip Inc Earnings Release - 4:00PM EDT - Add to calendar
Aug 8, 2016
Q2 2016 BioScrip Inc Earnings Call - 9:00AM EDT - Add to calendar
Jun 1, 2016
BioScrip Inc Annual Shareholders Meeting
May 10, 2016
BioScrip Inc Annual Shareholders Meeting (Estimated)
May 6, 2016
Q1 2016 BioScrip Inc Earnings Call - Webcast
May 5, 2016
Q1 2016 BioScrip Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -4.10% -30.89%
Operating margin -0.53% -29.29%
EBITD margin - 1.15%
Return on average assets -7.58% -44.77%
Return on average equity - -460.89%
Employees 1,844 -
CDP Score - -


1600 Broadway Ste 950
DENVER, CO 80202-4970
United States - Map
+1-720-6975200 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.

Officers and directors

Daniel E. Greenleaf Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Richard Michael Smith Vice Chairman of the Board
Age: 56
Bio & Compensation  - Reuters
Jeffrey M. Kreger Chief Financial Officer, Senior Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
Chris Luthin Chief Operating Officer, Senior Vice President - Field Finance
Bio & Compensation  - Reuters
Vito Ponzio Jr. Senior Vice President, Chief Administrative Officer
Age: 60
Bio & Compensation  - Reuters
Brian Stiver Senior Vice President of Sales and Marketing
Age: 52
Bio & Compensation  - Reuters
Donna Trujillo Senior Vice President of Human Resources
Age: 52
Bio & Compensation  - Reuters
David Evans Senior Vice President- Strategic Operations And Reimbursement
Age: 51
Bio & Compensation  - Reuters
C Britt Jeffcoat Chief Accounting Officer, Vice President, Controller
Bio & Compensation  - Reuters
Barbara Cormier Chief Compliance Officer and Privacy Officer
Age: 72
Bio & Compensation  - Reuters